关键字: 类型:
下载页码(大于1,小于132):
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
 制药提价与抑制仿制药方式 472条(本栏目收费,不能显示细节,电话13136136841)
esomeprazole (Nexium), 4 4
evergreening, 69 69
defined, 69 69
exclusivity period 180 0
days of under Paragraph IV certification, 22 22
parking of, 39 39
FDA drug approval before 1962, 28 28
changes after thalidomide crisis (1961), 28 28
citizen petitions and, 97,98 98
denial rates of generic- related petitions between 2001 and 2010, 94 94
Food and Drug Administration Safety and 0
Innovation Act (FDASIA) and, 97 97
generic delay and, 26 26
Kefauver- Harris Amendments and, 28 28
need for transparency in, 135,136 136
summary denial provision for citizen petitions and, 134 134
Federal Trade Commission (FTC) 0
on authorized generics, 60 60
decrease in pay- for- delay settlements post- FTC v. Actavis, 46 46
FTC v. Actavis, 43,45, 49,50, 65 65
FTC v. Actavis rule of reason test, 45,46 46
Felodipine. See Plendil (high blood pressure 0
drug, Mutual Pharmaceuticals) 0
Flonase (allergy drug, GlaxoSmithKline), 68 68
Food and Drug Administration Amendments Act (2007), 33 33
Food and Drug Administration Safety and 0
Innovation Act (FDASIA), 97 97
FTC v. Actavis, 24, 43,45, 49,50, 65 65
rule of reason test in, 45,46 46
Generation 1.0 strategies, 23,24. 23,24.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3